IKZF1 Deletions Are Markers of Treatment Resistance in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated within the Ongoing Risk-Adapted Pethema LAL19 Trial

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jordi Ribera, Isabel Granada, Teresa González, Mireia Morgades, Olga Garcia, Ricardo Sanchez, Esperanza Such, Susana Barrena, Juana Ciudad, Beatriz Soriano, Rocio Benito, Gayane Avetisyan, Eva Lumbreras, Cristina Miguel-García, Sandra Santos-Mínguez, Lurdes Zamora, Mar Mallo, Celia González-Gil, Eulàlia Genescà, Thaysa Lopes, Jesus Maria Hernández-Rivas, Alberto Orfao, Josep-Maria Ribera

Journal title: Blood

Journal number: 140 (Supplement 1)

Journal publisher: American Society of Hematology

Published year: 2022

Published pages: 6345–6347

DOI identifier: 10.1182/blood-2022-162159

ISSN: 0006-4971